Rockville, Maryland — September 24, 2026- Demand for wearable infusion adhesives is set to rise sharply, with the market expanding from USD 0.4 billion in 2026 to USD 1.4 billion by 2036 at a global CAGR of 13.3%. Growth is fueled by the widening use of wearable drug-delivery devices, continuous glucose monitoring systems, and home-based treatment that requires reliable, skin-friendly attachment over multi-day wear periods.

Acrylic adhesives are projected to lead with a 37.0% share in 2026, delivering dependable adhesion across varied conditions and extended wear while supporting patient comfort. CGM devices further anchor demand, accounting for 33.0% of the market as continuous glucose monitoring gains ground worldwide.

Get detailed market forecasts, competitive benchmarking, and pricing trends:

In the United States, the market is forecast to advance at 13.8% CAGR through 2036 as wearable drug-delivery systems and continuous glucose monitors see broader clinical and home adoption, with manufacturers prioritizing advanced adhesives for stability and comfort. Germany is expected to grow at 13.5% CAGR, driven by ongoing development of advanced wearable medical devices and rising preference for skin-friendly formulations that support digital-health initiatives. Japan is projected to expand at 13.2% CAGR, supported by an aging population that increases reliance on home-healthcare technologies and dependable adhesion for infusion and monitoring devices.

Key players including Solventum / 3M Medical Materials, Lohmann, Nitto Denko Corporation, and Henkel Adhesive Technologies continue refining breathable, low-trauma materials and strengthening partnerships with device makers to capture expanding opportunities in connected drug delivery and remote monitoring.

As wearable healthcare platforms proliferate, demand for high-performance infusion adhesives is positioned for sustained expansion—explore the full Fact.MR analysis for detailed segment and regional insights.

Unlock Actionable Insights from the Complete Report:

Note: Countries chosen (United States, Germany, Japan) as the three highest-CAGR markets in the report and the preferred Healthcare set (USA / Germany / Japan); Germany supplies the required European representation.

Explore More Related Studies Published by Fact.MR Research

Laryngeal Stents Market

Uveal Melanoma Treatment Market

Laser Cancer Therapy Market

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | [email protected]